Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04953715 · ClinicalTrials.gov registry record
Microbiome and Immunosuppression: The Mission Study
A clinical trial of Kidney Transplant and Kidney Transplant Rejection, sponsored by The University of Texas Medical Branch, Galveston.
- Active
- Registry status
- 140
- Enrollment target
- 2
- Study locations
NCT04953715: Active study of Kidney Transplant and Kidney Transplant Rejection, sponsored by The University of Texas Medical Branch, Galveston.
NCT04953715 is a study of Kidney Transplant and Kidney Transplant Rejection that is active but no longer recruiting, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 140 participants, below the 1,894-participant average among 30 other Kidney Transplant trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04953715, a study of Kidney Transplant and Kidney Transplant Rejection, is active but no longer recruiting, sponsored by The University of Texas Medical Branch, Galveston.
- ACTIVE NOT RECRUITING
- Registry status
- 140 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this research is to study immunosuppression drugs, certain foods, and how they can change the microbiome (the natural microorganisms inside the body) of the individual taking the immunosuppressive medications. The study team wants to study how the microbiome affects how the body processes the transplant medication.
Primary Outcome
The gut microbiome has been implicated in the Stool from tx recipients with diarrhea is often sent for testing of potential pathogenic organisms. polymerase chain reaction (PCR)- based approaches to identify etiology of post-tx diarrhea only tests for a limited number of organisms.
Conditions Studied
Interventions
- OTHER collection of body microbiome
Study Locations (2)
Minnesota
- University of Minnesota - Minneapolis
- HCMC - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2020-02-12 |
| Est. Completion | 2033-01-01 |
What the registry record for NCT04953715 still lists
NCT04953715 is an observational study that tracks outcomes without assigning an intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 1,894-participant average among 30 other Kidney Transplant trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Kidney Transplant appearing as the primary indexed condition, and to 1 intervention - of which collection of body microbiome is the first listed.
NCT04953715 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04953715 about?
NCT04953715 is a clinical study titled "Microbiome and Immunosuppression: The Mission Study". The purpose of this research is to study immunosuppression drugs, certain foods, and how they can change the microbiome (the natural microorganisms inside the body) of the individual taking the immunosuppressive medications. The study team wants to study how the microbiome affects how the body proce...
What is the current status of trial NCT04953715?
This trial is currently active not recruiting. The enrollment target is 140 participants. The study started on 2020-02-12. Estimated completion is 2033-01-01.
What conditions does trial NCT04953715 study?
This clinical trial studies the following conditions: Kidney Transplant, Kidney Transplant Rejection.
What interventions are being tested in trial NCT04953715?
The interventions under investigation include: collection of body microbiome (OTHER).
Who is sponsoring clinical trial NCT04953715?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04953715 being conducted?
This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04953715's enrollment target sits among peer trials
140 12th of 30 higher than 19 of 30 other Kidney Transplant trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Transplant trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
RECRUITING
-
Social Support Counseling Intervention for Kidney Transplant Candidates
RECRUITING · NA
-
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
RECRUITING · Phase 3
-
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
RECRUITING · Phase 3
-
Advancing Transplantation Outcomes in Children
RECRUITING · Phase 2
-
Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI